C9491 Avelumab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Avelumab

Brand Name:

Bavencio

Strength:

10 mg

HCPCS:

C9491

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Checkpoint Inhibitor

Minor Drug Class:

PD-1

Oral (Y/N):

No

FDA Approval Year:

2017

FDA Discontinuation Year:

CMS Effective Date:

Oct. 1, 2017

CMS Discontinuation Date:

Status:

In Use